Document is current
Any future updates will be listed below
-
Authors
Tsakiroglou, Maria
Harish, Pradeep
Hemingway, Harry
Blagden, Sarah P.
Gardner, Steve
O’Connor, Dan
Rentsch, Christopher T.
Ford, Grace
Saoulidis, Aris
Maclean, Rory H.
Denniston, Alastair K.
Pirmohamed, Munir
- License Information
-
More Information
Article History
Received: 9 March 2026
Accepted: 12 May 2026
First Online: 14 May 2026
Declarations
:
: Not applicable.
: Not applicable.
: All authors declare no support from any organisation for the submitted work. DO’C works for a trade association of innovative pharmaceutical industries, some of which are working on prevention solutions. SPB reports funding by Cancer Research UK, support from Prenostics and personal fees from Oxford Drug Design, Theolytics, UCB, and Oxford Hormone Clinic. AS is a clinical advisor for Datum bio, an AI-enabled health data, clinical decision support, and education company. SG is an employee and shareholder of PrecisionLife Ltd. MP currently receives partnership funding, paid to the University of Liverpool, for the MRC Medicines Development Fellowship Scheme (co-funded by MRC and GSK, AZ, Optum and Hammersmith Medicines Research). He has developed an HLA genotyping panel with MC Diagnostics but does not benefit financially from this. He is part of the IMI Consortium ARDAT ( ); none of these funding sources have been used for the current article.
